Combined tricuspid and pulmonic valve percutaneous replacement in a patient with a Glenn shunt.

@article{Mahadevan2016CombinedTA,
  title={Combined tricuspid and pulmonic valve percutaneous replacement in a patient with a Glenn shunt.},
  author={Vaikom S. Mahadevan and Jaspal S. Dua and Andreas Hoschtitzky},
  journal={International journal of cardiology},
  year={2016},
  volume={204},
  pages={
          128-30
        }
}
3 Citations
Combined Transcatheter Tricuspid and Pulmonary Valve Replacement
TLDR
Combined transcatheter tricuspid and pulmonary valve replacement can be performed successfully, with an acceptable complication rate, and is a feasible option for appropriately selected patients.
Transcatheter Interventions for Tricuspid Regurgitation: Rationale, Overview of Current Technologies, and Future Perspectives
Tricuspid regurgitation (most commonly functional) is a challenging therapeutic target in many patient subgroups such as patients with prior left-side valve surgery, congenital heart disease, cardiac
Catheter Device Therapies for Heart Failure
TLDR
This chapter will focus on interventions that can treat certain forms of congenital or postsurgical obstructive lesions, volume loading shunts, and other miscellaneous lesions leading to or exacerbating heart failure.

References

SHOWING 1-3 OF 3 REFERENCES
Clinical and Hemodynamic Outcomes up to 7 Years After Transcatheter Pulmonary Valve Replacement in the US Melody Valve Investigational Device Exemption Trial
TLDR
TPV replacement with the Melody valve provided good hemodynamic and clinical outcomes up to 7 years after implantation and a conduit prestent and lower discharge right ventricular outflow tract gradient were associated with longer freedom from reintervention.
Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the US Melody Valve Investigational Device Exemption Trial, Circulation
  • 2015
Percutaneous Tricuspid Valve Implantation: Two-Center Experience With Midterm Results
TLDR
It is thought that PTVI is a good alternative to repeated surgical TV replacements and that it may reduce the total number of open heart surgeries in patients with congenital heart disease.